BACKGROUND: Cardiac transplant arteriosclerosis or cardiac allograft vasculopathy remains the leading cause of graft failure and patient death in heart transplant recipients. Endothelial cell injury is crucial in the development of human atherosclerosis and may play a role in allograft vasculopathy. Glutathione-S-transferase (GST) is known to protect endothelial cells from damage by oxidants and toxins. However, the contribution of human GST A4-4 (hGSTA4-4) to vascular cell injury and consequent transplant arteriosclerosis is unknown. METHODS: A recombinant adenoviral vector containing hGSTA4-4 gene was constructed and delivered to vascular endothelial cells in an in vivo rabbit carotid artery transplant model. Forty-five days after transplantation, allografts were harvested (n=28). Blood flow was measured by ultrasonography. In addition, grafts were analyzed by histology, morphometry, immunostaining, and western blot. RESULTS: The severity of arteriosclerosis in hGSTA4-4 transduced allografts was compared with control by measuring degree of stenosis by neointima. Decrease in blood flow in hGSTA4-4 transduced allografts was significantly less than control allografts, which also developed greater intimal thickening and stenosis than hGSTA4-4 transduced allografts in the proximal and distal regions of the graft. Leukocyte and macrophage infiltration was reduced in hGSTA4-4 transduced carotid arteries. CONCLUSION: Our data indicate that hGSTA4-4 overexpression protects the integrity of vessel wall from oxidative injury, and attenuates transplant arteriosclerosis.
BACKGROUND:Cardiac transplant arteriosclerosis or cardiac allograft vasculopathy remains the leading cause of graft failure and patient death in heart transplant recipients. Endothelial cell injury is crucial in the development of humanatherosclerosis and may play a role in allograft vasculopathy. Glutathione-S-transferase (GST) is known to protect endothelial cells from damage by oxidants and toxins. However, the contribution of humanGST A4-4 (hGSTA4-4) to vascular cell injury and consequent transplant arteriosclerosis is unknown. METHODS: A recombinant adenoviral vector containing hGSTA4-4 gene was constructed and delivered to vascular endothelial cells in an in vivo rabbit carotid artery transplant model. Forty-five days after transplantation, allografts were harvested (n=28). Blood flow was measured by ultrasonography. In addition, grafts were analyzed by histology, morphometry, immunostaining, and western blot. RESULTS: The severity of arteriosclerosis in hGSTA4-4 transduced allografts was compared with control by measuring degree of stenosis by neointima. Decrease in blood flow in hGSTA4-4 transduced allografts was significantly less than control allografts, which also developed greater intimal thickening and stenosis than hGSTA4-4 transduced allografts in the proximal and distal regions of the graft. Leukocyte and macrophage infiltration was reduced in hGSTA4-4 transduced carotid arteries. CONCLUSION: Our data indicate that hGSTA4-4 overexpression protects the integrity of vessel wall from oxidative injury, and attenuates transplant arteriosclerosis.
Authors: Y Tomita; Q W Zhang; T Uchida; M Yoshikawa; I Shimizu; T Iwai; K Nomoto; H Yasui Journal: J Heart Lung Transplant Date: 2001-06 Impact factor: 10.247
Authors: Roope K Sihvola; Jussi M Tikkanen; Rainer Krebs; Eva M Aaltola; Elisabeth Buchdunger; Outi Laitinen; Petri K Koskinen; Karl B Lemström Journal: Transplantation Date: 2003-02-15 Impact factor: 4.939
Authors: Tao Wang; Chunming Dong; Susan C Stevenson; Edward E Herderick; Jennifer Marshall-Neff; Sanjay S Vasudevan; Nicanor I Moldovan; Robert E Michler; N Rao Movva; Pascal J Goldschmidt-Clermont Journal: Circulation Date: 2002-09-17 Impact factor: 29.690
Authors: G Vassalli; A Gallino; M Weis; W von Scheidt; L Kappenberger; L K von Segesser; J-J Goy Journal: Eur Heart J Date: 2003-07 Impact factor: 29.983
Authors: Danila Di Giuseppe; Paolo Di Simplicio; Pier Leopoldo Capecchi; Pietro Enea Lazzerini; Franco Laghi Pasini Journal: J Lab Clin Med Date: 2003-07
Authors: Silke Abele; Bernd M Spriewald; Martina Ramsperger-Gleixner; Martina Wollin; Nicola E Hiemann; Bernhard Nieswandt; Michael Weyand; Stephan M Ensminger Journal: Transplantation Date: 2009-01-27 Impact factor: 4.939